- Report
- August 2024
- 150 Pages
Global
From €2504EUR$2,789USD£2,132GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2694EUR$3,000USD£2,294GBP
- Clinical Trials
- April 2025
- 450 Pages
Global
From €4489EUR$5,000USD£3,823GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2694EUR$3,000USD£2,294GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1122EUR$1,250USD£956GBP
- Report
- February 2025
- 184 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- June 2024
- 183 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- March 2025
- 145 Pages
Global
From €3919EUR$4,365USD£3,337GBP
€4355EUR$4,850USD£3,708GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3232EUR$3,600USD£2,753GBP
- Report
- July 2023
- 220 Pages
Global
From €1787EUR$1,990USD£1,522GBP
- Report
- July 2021
- 50 Pages
China
From €2334EUR$2,600USD£1,988GBP
- Report
- June 2021
- 50 Pages
China
From €2334EUR$2,600USD£1,988GBP
- Report
- May 2021
- 50 Pages
China
From €2334EUR$2,600USD£1,988GBP
- Report
- May 2024
- 128 Pages
Global
From €5835EUR$6,499USD£4,969GBP
- Report
- May 2024
- 140 Pages
Global
From €5835EUR$6,499USD£4,969GBP
- Report
- May 2024
- 139 Pages
Global
From €5835EUR$6,499USD£4,969GBP
- Report
- March 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- January 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- August 2023
- 145 Pages
Global
From €2828EUR$3,150USD£2,408GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4265EUR$4,750USD£3,632GBP

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more